CXCL1 and breast neoplasm: Notably, the anti-cancer effect of TPCA-1 was partially attributed to CXCL1 inhibition since CXCL1 overexpressing EV-dead (EV-deadrCXCL1) reduced the inhibitory effect of TPCA-1 on EV-dead-induced breast tumor growth and metastasis.